AAO Updates Guideline on Otitis Media with Effusion
The American Academy of Otolaryngology-Head and Neck Surgery Foundation has released updated “Clinical Practice Guideline: Otitis Media with Effusion.”The Update of Guideline has been published in Journal of Otolaryngology-Head and Neck Surgery. This clinical practice guideline is an update and replacement for a guideline co-developed in 2004 by the American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP).An update was necessitated by new primary studies and systematic reviews that might suggest a need for modifying clinically important recommendations.The 18 recommendations developed emphasize diagnostic accuracy, identification of children who are most susceptible to developmental sequelae from otitis media with effusion, and education of clinicians and patients regarding the favorable natural history of most otitis media with effusion and the lack of efficacy for medical therapy (eg, steroids, antihistamines, decongestants).
The changes in content and methodology from the prior guideline include the following:
- Addition of consumer advocates to the guideline development group
- New evidence from 4 clinical practice guidelines, 20 systematic reviews, and 49 randomized controlled trials (RCTs)
- Emphasis on patient education and shared decision making with an optional grid for surgery and new tables of counseling opportunities and frequently asked questions
- Expanded action statement profiles to explicitly state quality improvement opportunities, confidence in the evidence, intentional vagueness, and differences of opinion
- Enhanced external review process to include public comment and journal peer review
- Additional information on pneumatic otoscopy and tympanometry to improve diagnostic certainty for otitis media with effusion (OME)
- Expanded information on speech and language assessment for children with OME
- New recommendations for managing OME in children who fail a newborn hearing screen, evaluating at-risk children for OME, and educating and counseling parents
- A new recommendation against using topical intranasal steroids for treating OME
- A new recommendation against adenoidectomy for a primary indication of OME in children <4 years old, including those with prior tympanostomy tubes, unless a distinct indication exists (nasal obstruction, chronic adenoiditis)
- A new recommendation for assessing OME outcomes by documenting OME resolution, improved hearing, or improved quality of life (QOL)
- A new algorithm to clarify decision making and action statement relationships
For further reference log on to : https://doi.org/10.1177/0194599815624407
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd